Explore the vast range of titles available.

Kevin P. Nannery, who supervised a band of corrupt officers called \"Nannery's Raiders,\" said in a Manhattan courtroom yesterday that the aide, Capt. Lewis T. Manetta, even handed him a sledgehammer for smashing into apartments in a Harlem building where they thought drugs were being sold in September 1990. Captain Manetta's lawyer, Richard A. Dienst, called his client one of the force's most honest and hardworking officers, and said that \"Nannery is totally and completely unworthy of belief.\" When asked on direct questioning by Florence Finkle, the prosecutor in the case, whether Captain Manetta had led other booming raids after that, Mr. Nannery said, \"There were a few others where Captain Manetta participated.\"

Malignant pleural effusion (MPE) is a common complication of lung cancer. One widely used treatment for MPE is Endostar, a recombined humanized endostatin based treatment. However, the mechanism of this treatment is still unclear. The aim of this study was to investigate the effects of Endostar in mice with MPE. Lewis lung carcinoma (LLC) cell line expressing enhanced green fluorescent protein (EGFP) was injected into pleural cavity to establish MPE mice model. Mice were randomly divided into four groups. High dose of Endostar (30 mg/kg), low dose of Endostar (8 mg/kg), normal saline, or Bevacizumab (5 mg/kg) was respectively injected into pleural cavity three times with 3-day interval in each group. Transverse computed tomography (CT) was performed to observe pleural fluid formation 14 days after LLC cells injection. Mice were anesthetized and sacrificed 3 days after final administration. The volume of pleural effusion n was measured using 1 ml syringe. Micro blood vessel density (MVD), Lymphatic micro vessel density (LMVD), the expression level of vascular endothelial growth factor A (VEGF-A) and VEGF-C were observed by immunohistochemistry (IHC) staining. The volume of pleural effusion as well as the number of pleural tumor foci, MVD and the expression of VEGF-A were significantly reduced in high dose of Endostar treat group. More importantly, LMVD and the expression of VEGF-C were markedly lower in treat group than those in the other three control groups. Our work demonstrated that Endostar played an efficient anti-cancer role in MPE through its suppressive effect on angiogenesis and lymphangiogenesis, which provided a certain theoretical basis for the effectiveness of Endostar on the MPE treatment.